Evidence map›Paper›PMID 39349603›Full record

ArticleNature methods2024

Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome.

Haiqi Xu, Linzhen Kong, Jingfei Cheng, Khatoun Al Moussawi, Xiufei Chen, Aleema Iqbal, Peter A C Wing, James M Harris, Senko Tsukuda, Azman Embarc-Buh and 6 more

Abstract read
In one paragraph

Article in Nature methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. The impact of psuedouridine modification on human tRNA.Biochemical Society transactions · 2026
    Review
  3. Article
  4. Article
  5. Pseudouridylation landscape across 42bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Haiqi Xu *Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0009-0006-4486-5075
Linzhen Kong *Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jingfei ChengLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Khatoun Al MoussawiLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Xiufei ChenLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Aleema IqbalLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0009-0009-7352-3033
Peter A C WingChinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
James M HarrisNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1880-3496
Senko TsukudaNuffield Department of Medicine, University of Oxford, Oxford, UK.
Azman Embarc-BuhMRC University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0002-1980-942X
Guifeng WeiDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-5698-426X
Alfredo CastelloMRC University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0002-1499-4662
Skirmantas KriaucionisLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2273-5994
Jane A McKeatingNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-7229-5886
Xin LuLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6587-1152
Chun-Xiao SongLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK. chunxiao.song@ludwig.ox.ac.uk.ORCID http://orcid.org/0000-0002-7781-6521

Funding

Chinese Academy of Medical Sciences (CAMS) 2018-I2M-2-002EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101001634RCUK | Medical Research Council (MRC) MC_UU_00034/2RCUK | Medical Research Council (MRC) MR/R021562/1Wellcome TrustWellcome Trust (Wellcome) 200838/Z/16/ZWellcome Trust (Wellcome) 225198/Z/22/Z
6 · The paper itself

Abstract

Pseudouridine (Ψ) is one of the most abundant modifications in cellular RNA. However, its function remains elusive, mainly due to the lack of highly sensitive and accurate detection methods. Here, we introduced 2-bromoacrylamide-assisted cyclization sequencing (BACS), which enables Ψ-to-C transitions, for quantitative profiling of Ψ at single-base resolution. BACS allowed the precise identification of Ψ positions, especially in densely modified Ψ regions and consecutive uridine sequences. BACS detected all known Ψ sites in human rRNA and spliceosomal small nuclear RNAs and generated the quantitative Ψ map of human small nucleolar RNA and tRNA. Furthermore, BACS simultaneously detected adenosine-to-inosine editing sites and N

Indexed as

PseudouridineTranscriptomeAdenosineHerpesvirus 4, HumanHumansIntramolecular TransferasesRNA, RibosomalRNA, Small NuclearRNA, Small NucleolarRNA, TransferRNA, ViralSequence Analysis, RNAAdenosineIntramolecular TransferasesPseudouridinepseudouridine synthasesRNA, RibosomalRNA, Small NuclearRNA, Small NucleolarRNA, TransferRNA, Viral

Identifiers

PMID39349603
PMCPMC11541003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.